Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.54 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 7/20 | 0.48 |
| ▸ | RAB9A | P51151 | 7/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5569924 | 0.84 | MEN1 (0.51) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31693367 | 0.83 | MEN1 (0.65) | HSP90AB1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL9720686 | 0.83 | MEN1 (0.65) | HSP90AB1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL2648128 | 0.83 | HSD11B1 (0.54) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL30016132 | 0.82 | GSK3B (0.59) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL9639259 | 0.82 | HSP90AB1 (0.69) | HSP90AB1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL11824924 | 0.82 | HSD11B1 (0.53) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL1434608 | 0.82 | GSK3B (0.59) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL8420333 | 0.82 | RAB9A (0.56) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL8744712 | 0.82 | HSD11B1 (0.53) | HSD11B1NPC1RAB9ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410077-A | Preparation method of 2,4, 6-trimethyl benzoic acid | 甘肃青宇新材料有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-108906124-B | Application of rare earth metal tricyclocene complex as catalyst in catalysis of synthesis reaction of ketone and pinacol borane | 苏州大学 | 2020-11-17 | — | — | CN | claimed |
| CN-101500996-B | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives | ACTELION PHARMACEUTICALS LTD | 2012-07-04 | — | — | CN | claimed |
| WO-1991010635-A1 | PROCESS FOR PREPARING 2,4,6-TRIMETHYLACETOPHENONE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-25 | — | — | WO | claimed |
| EP-0043480-B1 | PROCESS FOR FORMING METALLIC IMAGES | Hitachi, Ltd. (JP) | 1985-04-03 | — | — | EP | claimed |
| US-4347304-A | PHOTOSENSITIZATION WITH DISILANES OR ORGANIC COMPOUNDS HAVING COUPLED GERMANIUM OR TIN MOLECULES; PHOTORESISTS; POSITIVES; PLATING | HITACHI, LTD. (JP) | 1982-08-31 | — | — | US | claimed |
| US-12042788-B2 | Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis | THE UNIVERSITY OF CHICAGO (US) | 2024-07-23 | — | — | US | disclosed |
| CN-116854621-A | Photosensitizer taking pentamethine cyanine dye as matrix, and synthesis method and application thereof | 大连理工大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116410077-A | Preparation method of 2,4, 6-trimethyl benzoic acid | 甘肃青宇新材料有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116410077-A | Preparation method of 2,4, 6-trimethyl benzoic acid | 甘肃青宇新材料有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-113292606-B | Metal complex, organic electroluminescent material, light-emitting device, and electronic device | 北京八亿时空液晶科技股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| US-11440924-B2 | Method for preparing borate ester on basis of tricyclopentadienyl rare earth metal complex | SOOCHOW UNIVERSITY (CN) | 2022-09-13 | — | — | US | disclosed |
| US-11377442-B2 | Small molecule agonists and antagonists of NR2F6 activity | Zander Biologics, Inc (US) | 2022-07-05 | — | — | US | disclosed |
| EP-0046194-B1 | PROCESS FOR THE PREPARATION OF O,O-DISUBSTITUTED BENZOIC ACIDS AND THEIR SALTS | BASF Aktiengesellschaft (DE) | 1983-10-05 | — | — | EP | disclosed |
| US-4347304-A | PHOTOSENSITIZATION WITH DISILANES OR ORGANIC COMPOUNDS HAVING COUPLED GERMANIUM OR TIN MOLECULES; PHOTORESISTS; POSITIVES; PLATING | HITACHI, LTD. (JP) | 1982-08-31 | — | — | US | disclosed |
| EP-0046194-A1 | Process for the preparation of o,o-disubstituted benzoic acids and their salts | BASF Aktiengesellschaft (DE) | 1982-02-24 | — | — | EP | disclosed |
| US-4182730-A | Process for the preparation of substituted dihydrocinnamaldehydes via novel β-chlorocinnamaldehydes | GIVAUDAN CORPORATION (US) | 1980-01-08 | — | — | US | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-3975373-A | CYCLOPENTANONE HELVETICOSIDE | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-08-17 | — | — | US | disclosed |
| US-3951946-A | Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042788-B2 | Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis | CD69, TECR, MCM4 | HSD11B1 4228/4885HSP90AB1 4708/4885NPC1 3995/4885 |
| US-11440924-B2 | Method for preparing borate ester on basis of tricyclopentadienyl rare earth metal complex | ELOVL3, CDK3, NCAPD3 | HSD11B1 1188/4885HSP90AB1 4513/4885NPC1 1721/4885 |
| US-11377442-B2 | Small molecule agonists and antagonists of NR2F6 activity | NR4A2, NR2C2, NR2F2 | HSD11B1 1416/4885HSP90AB1 1937/4885NPC1 1681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.